GC Cell
144510.KQ
16.38 USD
-0.44
-2.62%
g
Overview
Last close
16.38 usd
Market cap
246.17M usd
52 week high
36.44 usd
52 week low
16.38 usd
Target price
52.25 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.8983
Price/Book Value
0.7011
Enterprise Value
320.97M usd
EV/Revenue
2.535
EV/EBITDA
32.491
Key financials
Revenue TTM
130.23M usd
Gross Profit TTM
68.45M usd
EBITDA TTM
7.15M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
656.87B usd
Net debt
N/A usd
About
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.
- Symbol144510.KQ
- ExchangeKQ
- IsinKR7144510005
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CEOJong-Eun Park
- HeadquarterYongin-si
- Web sitehttps://www.gccell.com
